The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: -2.00 (-0.39%)
Spread: 4.00 (0.791%)
Open: 508.00
High: 508.00
Low: 504.00
Prev. Close: 506.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Marlowe Plc

9 Mar 2016 09:00

RNS Number : 4543R
AIM
09 March 2016
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Marlowe plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

 

Fifth Floor

55 King Street

Manchester

M2 4LQ

 

COUNTRY OF INCORPORATION:

 

UK

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

www.marloweplc.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Marlowe plc ("Company" or "Marlowe") is a newly incorporated, UK-domiciled company which intends to merge with Marlowe Holdings Limited ("MHL"). MHL was admitted to trading on AIM in 2007 as a company established for the purpose of making investments in publicly traded or private companies. It is proposed that MHL should merge with Marlowe ("Merger") so that the ultimate holding company of Marlowe and its subsidiaries is a UK company, and that Marlowe should then be admitted to trading on AIM.

 

Marlowe has conditionally agreed subject, inter alia, to the completion of the Merger, to acquire Fire & Security (Group) Limited ("Swift"), one of the UK's leading national fire protection and security systems service providers. Subject to the completion of the acquisition, the provision of national fire protection and security systems services in the UK will be the substance of the Company's business going forward.

 

Swift was founded in 1982 by Nigel Jackson, a founding shareholder and the Managing Director who will join the board of Marlowe plc. Swift has a broad range of capabilities to design, install and service fire protection & security solutions.

 

The acquisition of Swift represents the first step towards building a dynamic business-to-business service group. The Directors intend to make further strategic acquisitions in the future. The Board has identified a number of companies which they believe are complementary to Swift and, if acquired, would enhance the market position of Swift. The potential acquisitions would also position the Company to develop a presence in other support service sectors which are complementary to the services provided by Swift.

 

The Company's main country of operation is the United Kingdom.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

The issued ordinary share capital to be admitted to trading on AIM at admission on 31 March 2016 will be 21,084,999 ordinary shares of 50 pence each, consisting of:

 

1) 1 existing ordinary share;

 

2) 14,584,998 new ordinary shares to be admitted pursuant to the Merger, which will be issued to existing MHL shareholders;

 

3) 3,000,000 new ordinary shares issued pursuant to a subscription to raise £3,000,000; and

 

4) 3,500,000 new ordinary shares to be issued as vendor consideration

 

The ordinary shares are freely transferable.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Gross proceeds of the Subscription: £3,000,000

 

Market capitalisation at admission at the Issue Price: £21,084,999

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

15.38%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Alexander Dacre - Chief Executive

Derek O'Neill - Interim Chairman and Finance Director

Charles Skinner - Non-executive Director

Peter Gaze - Non-executive Director

 

Nigel Jackson - Proposed Director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Shareholder

Percentage holding in Marlowe Holdings Limited prior to re domicile and Merger

Percentage holding prior to Admission

Percentage holding after Admission

Lord Michael Ashcroft KCMG PC

53.6

0.0

44.2

Derek O'Neill

2.9

0.0

3.2

Alex Dacre

22.9

100

16.6

Nigel Jackson

0

0.0

16.6

 

It is intended that MHL will merge with Marlowe shortly prior to Admission. On Admission shareholders in MHL will receive shares in Marlowe in exchange for their holdings in MHL.

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

N/A

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 March

(ii) Audited financial information for Swift to 31 May 2015. Audited and unaudited financial information for Marlowe to 30 September 2015

(iii) 30 September 2016, 31 December 2016, 30 September 2017

 

EXPECTED ADMISSION DATE:

 

31 March 2016

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Cenkos Securities plc

6.7.8 Tokenhouse Yard

London

EC2R 7AS

 

NAME AND ADDRESS OF BROKER:

 

Cenkos Securities plc

6.7.8 Tokenhouse Yard

London

EC2R 7AS

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

 

Cenkos Securities plc

6.7.8 Tokenhouse Yard

London

EC2R 7AS

 

DATE OF NOTIFICATION:

 

9 March 2016

 

NEW/ UPDATE:

 

New

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAZMGGFVRNGVZM
Date   Source Headline
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM
13th Sep 20237:00 amRNSAnnual General Meeting and Trading Update
4th Sep 20237:00 amRNSHolding(s) in Company
8th Aug 20237:00 amRNSExercise of Share Options and Total Voting Rights
7th Aug 20237:45 amRNSResponse to Speculation
4th Aug 20233:50 pmRNSHolding(s) in Company
3rd Aug 20235:25 pmRNSHolding(s) in Company
31st Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
26th Jul 20237:00 amRNSAcquisition of IMSM
18th Jul 202312:15 pmRNSCapital Reduction Effective
13th Jul 20232:00 pmRNSPublication of Notice of AGM and Annual Report
29th Jun 20237:00 amRNSPreliminary results
26th Jun 20237:00 amRNSNotice of Full Year Results
23rd Jun 20234:56 pmRNSHolding(s) in Company
19th Jun 202311:06 amRNSResult of General Meeting
5th Jun 20239:31 amRNSHolding(s) in Company
2nd Jun 20232:51 pmRNSPosting of Circular and Notice of General Meeting
2nd Jun 202312:36 pmRNSHolding(s) in Company
18th Apr 20231:45 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSCapital Markets Day Replay
28th Mar 20237:00 amRNSCapital Markets Day and Trading Update
7th Mar 20237:00 amRNSNotice of Capital Markets Event
28th Feb 20232:20 pmRNSHolding(s) in Company
26th Jan 20231:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSNotice of Capital Markets Event
2nd Dec 20229:00 amRNSNotice of Investor Presentation
1st Dec 202210:34 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSDirector/PDMR Shareholding
24th Nov 20222:14 pmRNSDirector/PDMR Shareholding
24th Nov 20221:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSHalf-year Report
21st Nov 202212:54 pmRNSExercise of Share Options and Total Voting Rights
17th Nov 20227:00 amRNSNotice of Interim Results
2nd Nov 20225:08 pmRNSHolding(s) in Company
19th Oct 202210:40 amRNSExercise of Share Options and Total Voting Rights
14th Oct 20223:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.